A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 52-Week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Testosterone (Primary)
- Indications Decreased libido
- Focus Registrational; Therapeutic Use
- Acronyms APHRODITE
- Sponsors Procter & Gamble
- 30 Mar 2010 Warner Chilcott added as trial sponsor and trial affiliate as reported by ClinicalTrials.gov.
- 06 Nov 2008 Results have been published in the NEJM.
- 04 Sep 2006 Status change